title: Antitumor effects of combined granulocyte macrophage colony stimulating factor and macrophage inflammatory protein-3 alpha plasmid DNA.
abstract: Dendritic cells (DC) are critical for priming adaptive immune responses to foreign antigens. However, the feasibility of harnessing these cells in vivo to optimize the antitumor effects has not been fully explored. The authors investigated a novel therapeutic approach that involves delivering synergistic signals that both recruit and expand DC populations at sites of intratumoral injection. More specifically, the authors examined whether the co-administration of plasmids encoding the chemokine macrophage inflammatory protein-3 alpha (pMIP3α) and plasmid encoding the granulocyte macrophage colony stimulating factor (pGM-CSF; a DC-specific growth factor) can recruit, expand and activate large numbers of DC at sites of intratumoral injection. It was found that the administration of pGM-CSF and pMIP3α resulted in dramatic recruitment and expansion of DC at these sites and in draining lymph nodes. Furthermore, treatment with pGM-CSF and pMIP3α generated the strongest MUC1-associated CD8+ T-cell immune responses in draining lymph nodes and in tumors, produced the greatest antitumor effects and enhanced survival rates more than pcDNA3.1, pGM-CSF alone and pMIP3α alone. It was also found that pGM-CSF plus pMIP3α generated the strongest MUC1-associated CD4+ T-cell immune responses in draining lymph nodes and in tumors. The findings of the present study suggest that the recruitment and activation of DC in vivo due to the synergistic actions of pGM-CSF and pMIP3α presents a potentially feasible means of controlling immunogenic malignancies and provides a basis for the development of novel immunotherapeutic treatments.
authors.affiliation: Department of Pathology, Seoul National University College of Medicine, Seoul, Korea.
authors.forename: Yun
authors.initials: Y
authors.lastname: Choi
authors.forename: Chul W
authors.initials: CW
authors.lastname: Kim
mesh_terms: D000818:Animals; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology / Q000378:metabolism; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology / Q000378:metabolism; D002452:Cell Count; D045744:Cell Line, Tumor; D054418:Chemokine CCL20 / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D003713:Dendritic Cells / Q000276:immunology*; D004797:Enzyme-Linked Immunosorbent Assay; D005240:Feasibility Studies; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D006801:Humans; D007371:Interferon-gamma / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D018396:Mucin-1 / Q000235:genetics / Q000276:immunology; D009374:Neoplasms, Experimental / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D010957:Plasmids / Q000008:administration & dosage / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction; D016019:Survival Analysis; D047368:Tumor Burden / Q000276:immunology
chemical_list: D054418:Chemokine CCL20; D018396:Mucin-1; D007371:Interferon-gamma; D016178:Granulocyte-Macrophage Colony-Stimulating Factor
references.citation: Cancer Immunol Immunother. 2004 Jan;53(1):17-25
references.pmid: 12955480
references.citation: J Biol Chem. 1997 Jun 6;272(23):14893-8
references.pmid: 9169459
references.citation: Nature. 1998 Mar 19;392(6673):245-52
references.pmid: 9521319
references.citation: J Clin Invest. 2004 Mar;113(5):774-83
references.pmid: 14991076
references.citation: J Immunol. 2002 May 15;168(10):4871-80
references.pmid: 11994436
references.citation: Mol Ther. 2007 May;15(5):1007-15
references.pmid: 17356539
references.citation: J Immunol. 1999 Jul 1;163(1):174-83
references.pmid: 10384114
references.citation: Cancer Lett. 1996 Mar 29;101(2):257-61
references.pmid: 8620478
references.citation: Annu Rev Immunol. 2000;18:245-73
references.pmid: 10837059
references.citation: J Exp Med. 1998 Jul 20;188(2):373-86
references.pmid: 9670049
references.citation: Cell. 2001 Aug 10;106(3):271-4
references.pmid: 11509176
references.citation: Science. 1999 Dec 10;286(5447):2098-102
references.pmid: 10617422
references.citation: J Immunol. 2000 Feb 15;164(4):1995-2000
references.pmid: 10657650
references.citation: Cancer Res. 2000 Feb 15;60(4):1035-42
references.pmid: 10706121
references.citation: Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3539-43
references.pmid: 8097319
references.citation: Semin Immunol. 2007 Feb;19(1):48-55
references.pmid: 17276695
references.citation: Immunity. 1998 Dec;9(6):757-63
references.pmid: 9881966
references.citation: Microbes Infect. 2000 Mar;2(3):257-72
references.pmid: 10758402
references.citation: Transplantation. 2002 Jan 15;73(1 Suppl):S7-11
references.pmid: 11810053
references.citation: Med Oncol. 1996 Sep;13(3):155-60
references.pmid: 9106174
references.citation: Curr Opin Immunol. 1997 Feb;9(1):10-6
references.pmid: 9039784
references.citation: J Immunol. 2003 Sep 1;171(5):2374-83
references.pmid: 12928384
references.citation: Hum Immunol. 1999 Jul;60(7):562-7
references.pmid: 10426272
references.citation: J Cancer Res Clin Oncol. 1995;121(9-10):587-92
references.pmid: 7559742
references.citation: J Exp Med. 1997 Sep 15;186(6):837-44
references.pmid: 9294138
references.citation: J Immunol. 2000 Oct 1;165(7):3797-803
references.pmid: 11034385
references.citation: J Immunol. 2005 May 15;174(10):5994-6004
references.pmid: 15879092
references.citation: Cancer. 2003 Jan 1;97(1):186-200
references.pmid: 12491520
references.citation: J Immunol. 1999 Jan 1;162(1):186-94
references.pmid: 9886385
references.citation: Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13722-7
references.pmid: 11717433
references.citation: Cancer Immunol Immunother. 1996 May;42(4):237-45
references.pmid: 8665571
references.citation: Hum Gene Ther. 1997 Jun 10;8(9):1065-72
references.pmid: 9189764
references.citation: J Exp Med. 1999 Jul 5;190(1):125-33
references.pmid: 10429676
references.citation: Cancer Gene Ther. 1996 Jan-Feb;3(1):39-47
references.pmid: 8785710
references.citation: J Immunol. 2000 Sep 1;165(5):2850-8
references.pmid: 10946318
references.citation: J Immunol. 2001 Nov 1;167(9):5077-83
references.pmid: 11673517
references.citation: J Immunol. 2002 Sep 15;169(6):2875-85
references.pmid: 12218100
references.citation: Springer Semin Immunopathol. 2000;22(4):345-69
references.pmid: 11155441